文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后综合征接受目标温度管理患者急诊风险分层的外部验证

External validation of a risk classification at the emergency department of post-cardiac arrest syndrome patients undergoing targeted temperature management.
PubMed 文献 · Resuscitation · 2019-05-30
一句话结论rCAST评分可高精度预测急诊PCAS并接受TTM患者的30天与90天神经功能结局,低(≤5.5)、中(6.0-14.0)、高(≥14.5)三级风险分类完成外部验证。

本研究为rCAST评分的外部验证,数据来自日本急诊医学会(JAAM)全国多中心前瞻性院外心脏骤停(OHCA)登记,纳入2014年6月至2015年12月在33-36 °C接受TTM的PCAS患者;12,024例OHCA患者中460例符合验证条件。rCAST预测30天和90天神经功能结局的AUC分别为0.892和0.895。低风险(rCAST≤5.5)敏感度0.95(95%CI 0.92-0.98)、特异度0.47(0.40-0.55);中风险(6.0-14.0)敏感度0.62(0.56-0.68)、特异度0.48(0.40-0.55);高风险(≥14.5)敏感度0.57(0.51-0.63)、特异度0.95(0.91-0.98)。作者认为rCAST预测神经功能结局准确性高,并据此提出三级风险分类。

要点

  • 在460例接受33-36 °C TTM的PCAS患者中,rCAST预测30天神经功能结局的AUC为0.892,预测90天为0.895。
  • 低风险组rCAST≤5.5:敏感度0.95(95%CI 0.92-0.98)、特异度0.47(0.40-0.55),适用于排除不良神经结局。
  • 高风险组rCAST≥14.5:特异度0.95(0.91-0.98)、敏感度0.57(0.51-0.63),可高特异度识别不良神经结局高风险患者。
  • 中风险组rCAST 6.0-14.0:敏感度0.62(0.56-0.68)、特异度0.48(0.40-0.55),预测区分能力弱于低、高风险两端。

适用人群与场景

  • 日本急诊医学会(JAAM)全国多中心前瞻性OHCA登记中,2014年6月至2015年12月期间在急诊接受33-36 °C目标温度管理(TTM)的心脏骤停后综合征(PCAS)患者,共460例纳入外部验证。

诊断标准与关键阈值

  • rCAST风险分层界值:低风险rCAST≤5.5,中风险rCAST 6.0-14.0,高风险rCAST≥14.5;用于预测30天和90天神经功能结局。

研究设计与关键结果

  • 研究类型为rCAST评分的外部验证,数据来自日本急诊医学会(JAAM)全国多中心前瞻性OHCA登记;12,024例OHCA患者中460例接受TTM的PCAS患者纳入分析。
  • rCAST预测30天神经功能结局的AUC为0.892,预测90天神经功能结局的AUC为0.895。
  • 低风险(rCAST≤5.5)预测结局的敏感度0.95(95%CI 0.92-0.98)、特异度0.47(0.40-0.55)。
  • 中风险(rCAST 6.0-14.0)预测结局的敏感度0.62(0.56-0.68)、特异度0.48(0.40-0.55)。
  • 高风险(rCAST≥14.5)预测结局的敏感度0.57(0.51-0.63)、特异度0.95(0.91-0.98)。

证据类型、等级与局限

  • 证据类型:预后评分外部验证研究,数据来源于日本急诊医学会(JAAM)全国多中心前瞻性OHCA登记。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为rCAST可用于高精度预测PCAS患者的神经功能结局,并据此建立了三级风险分类,可供急诊对接受TTM的PCAS患者进行风险分层参考。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: There are no established risk classification for post-cardiac arrest syndrome (PCAS) patients at the Emergency Department (ED) undergoing targeted temperature management (TTM). The aim of this study was to externally validate a simplified version of our prognostic score, the "post-Cardiac Arrest Syndrome for Therapeutic hypothermia score" (revised CAST [rCAST]) and estimate the predictive accuracy of the risk classification based on it.

METHODS: For the external validation, we used data from an out-of-hospital cardiac arrest (OHCA) registry of the Japanese Association for Acute Medicine (JAAM), which is a multicenter, prospective registry of OHCA patients across Japan. Eligible patients were PCAS patients treated with TTM at 33-36 °C between June 2014 and December 2015. We validated the accuracy of rCAST for predicting the neurological outcomes at 30 and 90 days.

RESULTS: Among the 12,024 OHCA patients, the data of 460 PCAS patients treated by TTM were eligible for the validation. The areas under the curve of rCAST for predicting the neurological outcomes at 30 and 90 days were 0.892 and 0.895, respectively. The estimated sensitivity and specificity of the risk categories for the outcomes were as follows: 0.95 (95% CI: 0.92-0.98) and 0.47 (0.40-0.55) for the low (rCAST: ≤5.5), 0.62 (0.56-0.68) and 0.48 (0.40-0.55) for the moderate (rCAST: 6.0-14.0), and 0.57 (0.51-0.63) and 0.95 (0.91-0.98) for the high severity category (rCAST: ≥14.5).

CONCLUSIONS: The rCAST was useful for predicting the neurological outcomes with high accuracy in PCAS patients, and the three grades was developed for a risk classification based on the rCAST.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Nishikimi M, Ogura T, Nishida K, et al. External validation of a risk classification at the emergency department of post-cardiac arrest syndrome patients undergoing targeted temperature management. Resuscitation. 2019. PMID: 31153943. doi:10.1016/j.resuscitation.2019.05.028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。